VIP Antagonist
VIP Antagonist structure
|
Common Name | VIP Antagonist | ||
|---|---|---|---|---|
| CAS Number | 125093-93-8 | Molecular Weight | 3467.06 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C154H257N49O40S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of VIP AntagonistVIPhyb (compound VIPhyb) is a vasoactive intestinal polypeptide (VIP) receptor antagonist that can be used in the study of cancers such as non-small cell lung cancer (NSCLC)[1]. |
| Name | H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2 |
|---|---|
| Synonym | More Synonyms |
| Description | VIPhyb (compound VIPhyb) is a vasoactive intestinal polypeptide (VIP) receptor antagonist that can be used in the study of cancers such as non-small cell lung cancer (NSCLC)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C154H257N49O40S |
|---|---|
| Molecular Weight | 3467.06 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast-maternal leukocyte interaction.
J. Leukoc. Biol. 98 , 49-58, (2015) Inducible regulatory T cells (Tregs) exert a timely and efficient immunosuppressive action at the critical peri-implantation stage essential for maternal tolerance to the conceptus. Vasoactive intesti... |
|
|
Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons.
BMC Gastroenterol. 12 , 30, (2012) Neuropathy is believed to be a common feature of functional and inflammatory intestinal diseases. Vasoactive intestinal peptide (VIP) is an acknowledged neuroprotective agent in peripheral, including ... |
|
|
Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.
Am. J. Physiol. 269(4 Pt 2) , H1467-72, (1995) We used three vasoactive intestinal polypeptide (VIP) antagonists, VIP-(10-28), [p-Cl-D-Phe6,Leu17]VIP, and NT-VIP, to evaluate the role of VIP as a mediator of vagally induced tachycardia in chloralo... |
| VIP ANTAGONIST |